Endotoxin detection firm Profos raises €5m
Profos AG, located in Regensburg, Germany, has raised €5 million in a financing round aimed at supporting the development of an endotoxin detection system with applications in biopharmaceutical production.
Profos AG, located in Regensburg, Germany, has raised €5 million in a financing round aimed at supporting the development of an endotoxin detection system with applications in biopharmaceutical production.
In the US, Altor BioScience has received a phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) to support development of its processes for making therapeutic antibodies in transgenic lettuce.
Researchers have developed a unique approach that predicts protein separation behaviour. The approach may reduce the time it takes to bring pharmaceuticals to market and may have significant implications for drug discovery.
Scientists in the UK have demonstrated their support for animal testing, insisting that animal experimentation is vital to medical breakthroughs.
Researchers at Rensselaer Polytechnic Institute in the US have developed a method to predict protein separation behaviour - directly from protein structure - that could reduce the time it takes to bring pharmaceuticals to market.
A new miniature biosensing laboratory device, which applies the benefits of micro- and nanotechnology, has been developed, which processes a patient's DNA indicating whether they are at risk of diseases, such as cancer.